日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immune cell senescence drives responsiveness to immunotherapy in melanoma.

免疫细胞衰老驱动黑色素瘤对免疫疗法的反应。

Pantelis Pavlos, Tremoulis Dimitrios Christos, Evangelou Konstantinos, Bakouros Panagiotis, Magkouta Sophia, Ntintas Orestis A, Veroutis Dimitris, Theocharous Giorgos, Kostopoulos Ioannis V, Thanos Dimitris-Foivos, Chatziioannou Eftychia, Anastasiou Ioanna A, Lagopati Nefeli, Valakos Dimitrios, Skaltsas Dimitrios, Pop Oltin Tiberiu, Abdou Marie Therese, Gagos Sarantis, Kletsas Dimitris, Thanos Dimitris, Stratigos Alexandros J, Röcken Martin, Flatz Lukas, Chrousos George P, Vlachakis Dimitrios, Tsitsilonis Ourania E, Petty Russell, Karamitros Timokratis, Gorgoulis Vassilis G

Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma

在一项针对肢端雀斑样黑色素瘤患者的国际队列研究中,程序性细胞死亡蛋白1和细胞毒性T淋巴细胞相关蛋白4的联合阻断治疗效果如何?

McGillivray, Erin; Ashouri, Karam; Chatziioannou, Eftychia; Gallegos, Jesús Antonio Ocejo; Zarka, Jabra; Kechter, Jacob; Hwang, Angelina S; Zhang, Kevin; Barros, Milton; Yeh, Justin; Okazaki, Ian; Crocker, Andrew B; Maeda, Takuya; Park, Soo J; Choi, Jacob; Andreoli, Mia; Darwish, Tarneem; Savage, David J; Kim, Kevin B; Gupta, Jayant; Shen, James; Shirai, Keisuke; Choi, April; Pai, Lori; Vazquez, Vinicius de Lima; Moser, Justin; Amaral, Teresa; Hernandez Aya, Leonel F; Lutzky, Jose; Najjar, Yana G; Costello, Collin M; Mangold, Aaron R; Bhatia, Shailender; Gibney, Geoffrey T; Farma, Jeffrey M; Daniels, Gregory A; Sosman, Jeffrey; Chandra, Sunandana; Mangla, Ankit; Bollin, Kathryn; Possik, Patrícia Abrão; Robles-Espinoza, Carla Daniela; Ito, Fumito; In, Gino K

Metastases in patients with adjuvant therapies: How to proceed?

接受辅助治疗的患者出现转移:如何处理?

Chatziioannou, Eftychia; Röcken, Martin

Discontinuation of immune checkpoint inhibitors for reasons other than disease progression and the impact on relapse and survival of advanced melanoma patients. A systematic review and meta-analysis

因疾病进展以外的原因停用免疫检查点抑制剂及其对晚期黑色素瘤患者复发和生存的影响:一项系统评价和荟萃分析

Lallas, Konstantinos; Chatziioannou, Eftychia; Durak, Derya; Frey, Georg; Serna-Higuita, Lina Maria; Rasch, Marie-Lena; Kyrgidis, Athanassios; Timotheadou, Eleni; Apalla, Zoe; Leiter, Ulrike; Flatz, Lukas; Lallas, Aimilios; Amaral, Teresa

Ecto-NOX Disulfide-Thiol Exchanger 2 (ENOX2/tNOX) Is a Potential Prognostic Marker in Primary Malignant Melanoma and May Serve as a Therapeutic Target.

外NOX二硫键-硫醇交换体2(ENOX2/tNOX)是原发性恶性黑色素瘤的潜在预后标志物,并可能作为治疗靶点

Böcker Matti, Chatziioannou Eftychia, Niessner Heike, Hirn Constanze, Busch Christian, Ikenberg Kristian, Kalbacher Hubert, Handgretinger Rupert, Sinnberg Tobias

Deep learning-based scoring of tumour-infiltrating lymphocytes is prognostic in primary melanoma and predictive to PD-1 checkpoint inhibition in melanoma metastases

基于深度学习的肿瘤浸润淋巴细胞评分可预测原发性黑色素瘤的预后,并可预测黑色素瘤转移中PD-1检查点抑制剂的疗效。

Chatziioannou, Eftychia; Roßner, Jana; Aung, Thazin New; Rimm, David L; Niessner, Heike; Keim, Ulrike; Serna-Higuita, Lina Maria; Bonzheim, Irina; Kuhn Cuellar, Luis; Westphal, Dana; Steininger, Julian; Meier, Friedegund; Pop, Oltin Tiberiu; Forchhammer, Stephan; Flatz, Lukas; Eigentler, Thomas; Garbe, Claus; Röcken, Martin; Amaral, Teresa; Sinnberg, Tobias

Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy

接受抗PD-1免疫疗法治疗后达到完全缓解的IV期黑色素瘤患者的特征和长期预后

Chatziioannou, Eftychia; Leiter, Ulrike; Thomas, Ioannis; Keim, Ulrike; Seeber, Olivia; Meiwes, Andreas; Boessenecker, Isabell; Gonzalez, Stephanie Sanchez; Torres, Francisco Merraz; Niessner, Heike; Sinnberg, Tobias; Forschner, Andrea; Flatz, Lukas; Amaral, Teresa